Public statement for collaboration on COVID-19 vaccine development

On April 13, 2020, the World Health Organization (WHO) published a Public statement for collaboration on COVID-19 vaccine development. The statement read:1)

“We are scientists, physicians, funders and manufacturers who have come together as part of an international collaboration, coordinated by the World Health Organization (WHO), to help speed the availability of a vaccine against COVID-19. While a vaccine for general use takes time to develop, a vaccine may ultimately be instrumental in controlling this worldwide pandemic. In the interim, we applaud the implementation of community intervention measures that reduce spread of the virus and protect people, including vulnerable populations, and pledge to use the time gained by the widespread adoption of such measures to develop a vaccine as rapidly as possible. We will continue efforts to strengthen the unprecedented worldwide collaboration, cooperation and sharing of data already underway. We believe these efforts will help reduce inefficiencies and duplication of effort, and we will work tenaciously to increase the likelihood that one or more safe and effective vaccines will soon be made available to all.”

Signatories

Name Affiliation
Randy Albrecht Icahn School of Medicine at Mount Sinai
Mohamad Assoum Mercy Global Health
Luigi Aurisicchio Takis Biotech
Dan Barouch Center for Virology and Vaccine Research
Trevor Brasel University of Texas Medical Branch (UTMB)
Jennifer Bath ImmunoPrecise Antibodies
Sina Bavari Edge BioInnovation Consulting and Management
Maria Elena Bottazzi Baylor College of Medicine
Gerhard Beck Austrian Medicines and Medical Devices
Tom Brady Flow Pharma
Kate Broderick Inovio Pharmaceuticals
Will Brown Altimmune
Dirk Busch German Center for Infection Research (DZIF)
Maura Dandri German Center for Infection Research (DZIF)
Dirk Heinz German Center for Infection Research (DZIF)
Hans-Georg Kraeusslich German Center for Infection Research (DZIF)
Scot Bryson Orbital Farm
Ricardo Carrión Texas Biomedical Research Institute
Miles Carroll Public Health England
Keith Chappell University of Queensland
Daniel Chertow National Institutes of Health (NIH)
Sandra Cordo Universidad de Buenos Aires
Wian de Jongh Prevent n-CoV Consortium (AdaptVac, ExpreS2ion Biotechnologies, Copenhagen University, Leiden University Medical Centre, Wageningen University and Tubingen University)
Natalie Dean University of Florida
Rafael Delgado Hospital Universitario 12 de Octubre
Dimiter Dimitrov -
David Dodd GeoVax
Paul Duprex Center for Vaccine Research, University of Pittsburgh
Luis Enjuanes Centro Nacional Biotecnología
Jeremy Farrar Wellcome Trust
Josie Golding Wellcome Trust
Charlie Weller Wellcome Trust
Mark Feinberg International AIDS Vaccine Initiative (IAVI)
Swati Gupta International AIDS Vaccine Initiative (IAVI)
Ripley Ballou International AIDS Vaccine Initiative (IAVI)
Antonella Folgori ReiThera
Thomas Friedrich University of Wisconsin School of Veterinary Medicine
Simon Funnel Public Health England
Luc Gagnon Nexelis
Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai
Vipin Garg Altimmune
Volker Gerdts Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac), University of Saskatchewan
Nora Gerhards Wageningen Bioveterinary Research
Christiane Gerke Institut Pasteur
Carlo Giaquinto University of Padova
Prakash Ghimire Tribhuvan University
Nikolaj Gilbert Program for Appropriate Technology in Health (PATH)
Sarah Gilbert University of Oxford
Marion Gruber Food and Drug Administration (FDA)
Farshad Guirakhoo GeoVax
Bart Haagmans Erasmus Medical Center (EMC)
M. Elizabeth Halloran Center for Inference and Dynamics of Infectious Diseases, Fred Hutchinson Cancer Research Center, and University of Washington
Scott Harris Altimmune
Hideki Hasegawa National Institute of Infectious Diseases
Richard Hatchett Coalition for Epidemic Preparedness Innovations (CEPI)
James Hayward Applied DNA Sciences
Sheri Ann Hild -
Peter Hotez Baylor College of Medicine
Youngmee Jee Seoul National University
Charu Kaushic Institute of Infection and Immunity, Canadian Institutes of Health Research (CIHR)
Alyson Kelvin Dalhousie University
Larry Kerr United States Department of Health and Human Services (HHS)
Bernard Kerscher Paul Ehrlich Institute (PEI)
Jae-Ouk Kim International Vaccine Institute
Seungtaek Kim Institut Pasteur Korea
Jason Kindrachuk University of Manitoba
Otfried Kistner “Senior Consultant and Independent Vaccine Expert”
Gary Kobinger Université Laval
Marion Koopmans Erasmus Medical Centre (EMC)
Jeroen Kortekaas Wageningen Bioveterinary Research
Philip Krause Food and Drug Administration
Greg Kulnis Nexelis
Paul Henri Lambert Centre of Vaccinology, University of Geneva
Nathalie Landry Medicago
Roger Le Grand Inserm-CEA-Université Paris Saclay
Robin Levis Food and Drug Administration
Mark Lewis Bioqual
Joshua Liang Clover Biopharmaceuticals
Jinzhong Lin Fudan University
Ira Longini University of Florida
Shabir Madhi University of the Witwatersrand
Jessica Manning National Institutes of Health
Peter Marks Food and Drug Administration, Center for Biologics Evaluation and Research
Hilary Marston National Institutes of Health
Federico Martinón-Torres Hospital Clínico Universitario de Santiago de Compostela
Sebastian Maurer-Stroh Global Initiative on Sharing All Influenza Data (GISAID)
John Mellors University of Pittsburgh School of Medicine
Ali Mirazimi Karolinska Institute
Kayvon Modjarrad Walter Reed Army Institute of Research
Stefan Mueller CureVac
Vincent Munster National Institutes of Health
César Muñoz-Fontela Bernhard-Nocht-Institute for Tropical Medicine
Aysegul Nalca United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
José Manuel Ochoa Altimmune
Dave O'Connor University of Wisconsin-Madison
Lidia Oostvogels CureVac
Nisreen M. A. Okba Erasmus Medical Center
L. Jean Patterson National Institutes of Health
Joe Payne Arcturus Therapeutics
Jonathan Pearce UK Research and Innovation (UKRI), Medical Research Council (MRC)
Stanley Perlman University of Iowa
Margaret Louise Pitt Walter Reed Army Institute of Research, United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
Anuradha Poonepalli Health Sciences Authority
Dieter Pullirsch Austrian Medicines and Medical Devices Agency
Damian Purcell Peter Doherty Institute for Infection and Immunity
Chuan Qin Institute of Laboratory Animal Sciences (ILAS), Chinese Academy of Medical Sciences & Peking Union Medical College (PUMC)
Angela Rasmussen Columbia University Mailman School of Public Health
Scott Roberts Altimmune
Estefania Rodriguez Bernhard Nocht Institute for Tropical Medicine
Ted Ross Center for Vaccines and Immunology, University of Georgia
Chad Roy Tulane National Primate Research Center, Tulane School of Medicine
Reid Rubsamen Flow Pharma
Anna Laura Salvati -
Andrew Satz EVQLV
Hanneke Schuitemaker Janssen
Johan Van Hoof Janssen
Robert Shattock Imperial College London
John Shriver Sanofi
Gale Smith Novavax
Peter Smith London School of Hygiene and Tropical Medicine
Isabel Sola Centro Nacional Biotecnología
James Southern South African Health Products Regulatory Authority
Ryan Spencer Dynavax
David Novack Dynavax
Jonathan Spergel Children’s Hospital of Philadelphia, Perelman School of Medicine
Sybil Tasker Codagenix
Chien-Te Kent Tseng University of Texas Medical Branch
Jean Marie Vianney Habarugira European & Developing Countries Clinical Trials Partnership (EDCTP)
Veronika von Messling German Federal Ministry of Education and Research
Tony Wang Food and Drug Administration
Jeffrey Wolf Heat Biologics
Ningshao Xia Xiamen University of China
Yingjie Xu Shanghai Jiaotong University
Paul Young University of Queensland
Hang Yu Shanghai RNACure
Xuefeng Yu CanSino Biologics
Tal Zaks Moderna
Peter Daszak EcoHealth Alliance
1)
Jasarevic, T. (2020, April 16). Public statement for collaboration on COVID-19 vaccine development. World Health Organization. http://archive.today/2020.10.04-153106/https://www.who.int/news-room/detail/13-04-2020-public-statement-for-collaboration-on-covid-19-vaccine-development
Back to top